Patents by Inventor Suil Kim

Suil Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240382601
    Abstract: In one aspect, the present disclosure provides a complex containing kojyl methylenedioxycinnamate; a compound containing an ethylene glycol moiety or a propylene glycol moiety; a surfactant containing a saccharide moiety; and an antioxidant, and an emulsion formulation containing the complex. In another aspect, the present disclosure provides a method for manufacturing the complex, comprising: (a) adding kojyl methylenedioxycinnamate, a compound containing an ethylene glycol moiety or a propylene glycol moiety, a surfactant containing a saccharide moiety, and an antioxidant; and (b) homomixing the result of the (a).
    Type: Application
    Filed: May 10, 2024
    Publication date: November 21, 2024
    Applicants: AMOREPACIFIC CORPORATION, DKBIO CO., LTD
    Inventors: Jaewon YOU, Suil KIM, Yujung KIM, Jong Eoun HONG
  • Patent number: 11654094
    Abstract: The present specification relates to a composition for external application to skin with improved solubility and feeling during use, comprising a benzoic acid amide compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solute that is a solvate thereof, and a first cyclodextrin solubilizing agent.
    Type: Grant
    Filed: March 26, 2018
    Date of Patent: May 23, 2023
    Assignee: AMOREPACIFIC CORPORATION
    Inventors: Chang-geun Yi, Suil Kim, Sung Il Park, Hong-ju Shin
  • Publication number: 20210093532
    Abstract: The present specification relates to a composition for external application to skin with improved solubility and feeling during use, comprising a benzoic acid amide compound, an isomer thereof, a pharmaceutically acceptable salt thereof, a hydrate thereof or a solute that is a solvate thereof, and a first cyclodextrin solubilizing agent.
    Type: Application
    Filed: March 26, 2018
    Publication date: April 1, 2021
    Applicant: AMOREPACIFIC CORPORATION
    Inventors: Chang-geun YI, Suil KIM, Sung Il PARK, Hong-ju SHIN
  • Patent number: 7172869
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Grant
    Filed: April 20, 2004
    Date of Patent: February 6, 2007
    Assignees: The United States of America as represented by the Secretary of the Navy, The Regents of the University of Michigan
    Inventors: Carl H. June, Thompson B. Craig, Suil Kim
  • Publication number: 20060246587
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Application
    Filed: June 28, 2006
    Publication date: November 2, 2006
    Applicants: The United States of America as Represented by the Secretary of the Navy, The Regents of the University of Michigan
    Inventors: Carl June, Craig Thompson, Suil Kim
  • Patent number: 7067318
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Grant
    Filed: September 9, 2003
    Date of Patent: June 27, 2006
    Assignees: The Regents of the University of Michigan, The United States of America as represented by the Secretary of the Navy
    Inventors: Carl H. June, Craig B. Thompson, Suil Kim
  • Publication number: 20040203155
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Application
    Filed: April 20, 2004
    Publication date: October 14, 2004
    Applicants: The United States of America as Represented by the Secretary of the Navy, The Regents of the University of Michigan
    Inventors: Carl H. June, Craig B. Thompson, Suil Kim
  • Publication number: 20040087025
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Application
    Filed: September 9, 2003
    Publication date: May 6, 2004
    Applicants: The United States of America as Represented by the Secretary of the Navy, The Regents of the University of Michigan
    Inventors: Carl H. June, Craig B. Thompson, Suil Kim
  • Patent number: 6692964
    Abstract: A method for transfecting T cells with a nucleic acid molecule comprising a gene such that the gene is expressed in the T cells is described. The T cells are stimulated and proliferating prior to introduction of the nucleic acid molecule.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: February 17, 2004
    Assignees: The United States of America as represented by the Secretary of the Navy, The Regents of the University of Michigan
    Inventors: Carl H. June, Craig B. Thompson, Suil Kim